Author:
McNeely Jennifer,Arnsten Julia H,Gourevitch Marc N
Abstract
Abstract
Background
We sought to assess injection practices, means of acquiring and disposing of syringes, and utilization and knowledge of harm reduction resources among injection drug users (IDUs) entering methadone maintenance treatment (MMT).
Methods
Interviews with 100 consecutive patients, including 35 IDUs, entering a MMT program in the Bronx, NY.
Results
Utilization of unsafe syringe sources was reported by 69% of IDUs in our sample. Most (80%) IDUs reused syringes, and syringe sharing was also common. Fewer than half knew that non-prescription pharmacy purchase of syringes was possible. The most common means of disposing of injecting equipment were the trash (63%) and syringe exchange programs (49%).
Conclusions
These findings indicate that drug users entering treatment under-utilize sanctioned venues to obtain sterile syringes or safely dispose of used injection equipment. Programs providing services to drug users should adopt a proactive stance to address the safety and health issues faced by injectors.
Publisher
Springer Science and Business Media LLC
Subject
Psychiatry and Mental health,Public Health, Environmental and Occupational Health,Medicine (miscellaneous)
Reference32 articles.
1. U.S. Department of Health and Human Services, Public Health Service: HIV prevention bulletin: Medical advice for persons who inject illicit drugs. May 9, 1997, Accessed March 9, 2004, [http://www.cdc.gov/idu/pubs/hiv_prev.htm]
2. Centers for Disease Control and Prevention: Viral Hepatitis and Injection Drug Users. 2002, Accessed May 31, 2004., [http://www.cdc.gov/idu/hepatitis/viral_hep_drug_use.htm]
3. Normand J, Vlahov D, Moses LE, (Eds): Preventing HIV transmission: The role of sterile needles and bleach. 1995, Washington, DC: National Academy Press
4. Lurie P, Jones TS, Foley J: A sterile syringe for every drug user injection: How many injections take place annually, and how might pharmacists contribute to syringe distribution?. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology. 1998, 18 (Suppl 1): S45-S51.
5. Gleghorn AA, Wright-De Aguero L, Flynn C: Feasibility of one-time use of sterile syringes: A study of active injection drug users in seven United States metropolitan areas. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology. 1998, 18 (Suppl 1): S30-S36.
Cited by
10 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献